Pharmaceutical Granulators Market Future Growth Analysis report 2021-2028 | L.B. Bohle, Alexanderwerk, GEA Group Aktiengesellschaft, Frewitt S.A

Global Pharmaceutical Granulators Market, is estimated to account for US$ 3,435.8 million in 2020, and is projected to witness a CAGR of 5.6% over the forecast period 2021-2028.

Granulators are the rotor machines which turn fine powder into granules by a range of physical procedures. Granulation is the process where tiny particles are collected together for forming a big permanent mass. Applications of the granulation process include in the pharmaceutical field to manufacture tablets, capsules, as well as other types of medicines.

To Get more Business Statergies Request for Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/1649

Rapidly advancing pharmaceutical industry is expected drive growth of the global pharmaceutical granulators market over the forecast period. Insufficient capability of production of manufacturing sites is expected to hamper the high volume pharmaceutical demands. As per the National Center for Biotechnology Information in 2017, fluid bed drying and high sheer wet granulation were recognized as vital unit operations which impact the formulation of drug dosage. The pharmaceutical players are establishing novel manufacturing facilities along with expanding the existing ones with respect to upgradation of the manufacturing procedures and equipment.

For instance, Fresenius Kabi, in November 2017, invested over US$ 100 Mn to expand its manufacturing operation at Wilson, North Carolina. Likewise, Piramal Pharma Solutions, an India-based drug manufacturer, in October 2017, invested over US$ 55 Mn to expand the units of API manufacturing in India and North America.
Moreover, the market companies are also focused on enhancing performance of granulators. Key players are focusing on developing innovative and novel solutions for maintaining a leading position within the market. For instance, L B Bohle Maschinen, in June 2015, launched BRC 25, a little dry granulator having low maintenance for an easy handling, small footprint, and continuous production.

Moreover, Bosch Packaging Technology, in 2015, introduced a novel granulation unit named GranuLean which facilitates a quick and complete granulation procedure for the pharmaceutical ingredients within compact unit size. The market companies are focusing on adoption of strategies of direct marketing through participation in several conferences, trade fairs, and others. For instance, Buhler Group, in March 2017, presented and displayed at the VIV ASIA 2017, its latest novel AHPE900 granulator, as their marketing strategy.

Various initiatives by non-governmental and governmental organizations for scaling up the process of pharmaceutical manufacturing resulting in a range of new manufacturing entrants in the sector of pharmaceutical production is a key factor expected to drive growth of the global pharmaceutical granulators market over the forecast period.

To Get Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/1649

Entry of regional players within pharmaceutical industry is supported by subsidies and funding offered by the government to such players regarding equipment set-up and facility which aids the players to start mid-sized and small manufacturing units. The granulator is an important part of such units, since these are unit processors of primary stage in formulations of oral dosage. For instance, as per the Union Budget of India 2015 - 16 provisions, the national center for developing bulk drugs as well as facilitating its research was developed within Hyderabad, India.

Global Pharmaceutical Granulators Market: Key Takeaways

• The global pharmaceutical granulators market is expected to witness a 5.6% CAGR during the forecast period (2019-2027), due to automation of the procedures of drug development consisting installation of modified automatic tools, which is expected to propel the pharmaceutical granulator demand. For instance, Boehringer Ingelheim, in July 2017, invested US$ 217 Mn to upgrade and expand its manufacturing operation within Fremont, California.

• Based on product type, the segment of high shear mixer granulators is expected to account for the highest share in the global pharmaceutical granulators market due to rising high-shear granulator demands in pharmaceutical R&D.

• Key players functioning in the global pharmaceutical granulators market are L.B. Bohle, GEA Group Aktiengesellschaft, Alexanderwerk, Frewitt S.A., Spraying Systems Co., LINXIS Group, Syntegon Technology GmbH, Gebrüder Lödige Maschinenbau GmbH, Glatt GmbH, and Romaco Group.

To Direct Purchase this Research Report – https://www.coherentmarketinsights.com/insight/buy-now/1649

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Coherent Market Insights :

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.